Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Faiza Saeed Speaks at The Paley Center for Media’s 2023 International Council Summit

November 17, 2023

Cravath partner Faiza J. Saeed participated in The Paley Center for Media’s 2023 International Council Summit, which was held in New York from November 7‑8, 2023. In a session on November 7 entitled “Media M&A: How Modern Media Giants Are Operating in Uncertain Financial Times,” Faiza spoke with Centerview Partners LLC partner and co‑founder Blair Effron about the influence of M&A on the evolving media landscape and the future outlook of deals and deal‑making against the backdrop of technological change and disruption.

Related Practices & Industries

  • Corporate
  • Mergers and Acquisitions
  • Media and Entertainment
  • Technology

Speakers

Photo
Name
Faiza J. Saeed
Title
Corporate
Title
Partner
Email
fsaeed@cravath.com
Phone
+1-212-474-1454
vCard
Download vCard

    Education

    • J.D., 1991, Harvard Law School
      magna cum laude
    • B.A., 1987, University of California, Berkeley
      with Highest Distinction, Phi Beta Kappa

    Admitted In

    • New York
    • California (Inactive)
    • District of Columbia (Inactive)

    Related News & Insights

    Deals & Cases

    October 17, 2023

    Thermo Fisher Scientific’s Acquisition of Olink

    On October 17, 2023, Thermo Fisher Scientific Inc. (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”), a leading provider of next generation proteomics solutions, announced that their respective boards of directors have approved Thermo Fisher’s proposal to acquire Olink for $26.00 per common share in cash, representing $26.00 per American Depositary Share in cash. Thermo Fisher will commence a tender offer to acquire all of the outstanding Olink common shares and all of the American Depositary Shares. The transaction values Olink at approximately $3.1 billion which includes net cash of approximately $143 million. Cravath is representing Thermo Fisher in connection with the transaction.

    Deals & Cases

    August 04, 2023

    Hasbro’s Sale of its eOne Film and TV Business to Lionsgate

    On August 3, 2023, Hasbro, Inc., a leading toy and game company, announced that it has reached a definitive agreement to sell its eOne film and TV business to Lionsgate for approximately $500 million, consisting of $375 million in cash, subject to certain purchase price adjustments, and the assumption by Lionsgate of production financing loans. Cravath is representing Hasbro in connection with the transaction.

    Deals & Cases

    July 28, 2023

    Biogen’s $7.3 Billion Acquisition of Reata Pharmaceuticals

    On July 28, 2023, Biogen Inc. (“Biogen”) and Reata Pharmaceuticals, Inc. (“Reata”) announced that they have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion. Cravath is representing Biogen in connection with the transaction.

    Deals & Cases

    May 25, 2023

    Illumina’s Proxy Contest Against Carl Icahn

    On May 25, 2023, Illumina, a global leader in DNA sequencing and array‑based technologies, announced that Illumina shareholders have voted to elect eight of nine Illumina director nominees to the Board of Directors. Cravath represented Illumina in connection with these matters.

    Cravath Bicentennial

    Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

    Explore

    Cravath, Swaine & Moore LLP Logo
    • CONTACT US
    • OUR STORY
    • ALUMNI PORTAL
    • DISCLAIMERS & NOTICES

    Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.